Background:Intraoperative transcranial motor-evoked potential (TCMEP) monitoring is widely performed during neurosurgical operations. Sensitivity and specificity in TCMEP during neurosurgical operations were examined according to the type of operation.Methods:TCMEP monitoring was performed during 283 neurosurgical operations for patients without preoperative motor palsy, including 121 spinal operations, 84 cerebral aneurysmal operations, and 31 brain tumor operations. Transcranial stimulation at 100–600 V was applied by screw electrodes placed in the scalp and electromyographic responses were recorded with surface electrodes placed on the affected muscles. To exclude the effects of muscle relaxants on TCMEP, compound muscle action potential (CMAP) by supramaximal stimulation of the peripheral nerve immediately after transcranial stimulation was used for compensation of TCMEP.Results:In spinal operations, with an 80% reduction in amplitude as the threshold for motor palsy, the sensitivity and specificity with CMAP compensation were 100% and 96.4%, respectively. In aneurysmal operations, with a 70% reduction in amplitude as the threshold for motor palsy, the sensitivity and specificity with CMAP compensation were 100% and 94.8%, respectively. Compensation by CMAP was especially useful in aneurysmal operations. In all neurosurgical operations, with a 70% reduction in amplitude as the threshold for motor palsy, the sensitivity and specificity with CMAP compensation were 95.0% and 90.9%, respectively.Conclusions:Intraoperative TCMEP monitoring is a significantly reliable method for preventing postoperative motor palsy in both cranial and spinal surgery. A 70% reduction in the compensated amplitude is considered to be a suitable alarm point in all neurological operations.

It is often difficult to evaluate the results of transcranial motor-evoked potential (TCMEP) monitoring in patients under general anesthesia because these results are strongly affected by anesthetics and muscle relaxants. To exclude effects of muscle relaxants on TCMEP, compound muscle action potential (CMAP) by supramaximum stimulation of the median nerve immediately after transcranial stimulation (300 to 600 V) was recorded in 70 neurosurgical operations. A relative amplitude index (RAI) was defined as the amplitude of TCMEP after the operative procedure divided by the amplitude of TCMEP before the operative procedure. The RAI was calculated and was compensated by the amplitude of CMAP in 141 limbs. In 12 limbs of 7 patients with postoperatively progressed motor paresis, the compensated RAI was less than 0.2. The compensated RAI in all other 129 limbs of 63 patients without postoperative motor palsy was more than 0.2. These results suggest that compensation of TCMEP monitoring by CMAP is an easy and accurate method for removing the effects of muscle relaxants in TCMEP.

Background Although intraoperative motor-evoked potential (MEP) monitoring is widely performed during neurosurgical operations, evaluating its results is controversial. Study Aims The cutoff point of MEP monitoring should be determined not only to predict but also to prevent postoperative neurologic deficits. Material and Methods MEP monitoring was performed during 484 neurosurgical operations for patients without definitive preoperative motor palsy including 325 spinal operations, 102 cerebral aneurysmal operations, and 57 brain tumor operations, all monitored by transcranial stimulation, and 34 brain tumor operations monitored under direct cortical stimulation. To exclude the effects of muscle relaxants on MEP, the compound muscle action potential (CMAP), measured immediately after transcranial stimulation or direct cortical stimulation at supramaximal stimulation of the peripheral nerve, was used for normalization. The cutoff points, sensitivity, and specificity of MEP recorded during neurosurgery were examined by receiver operating characteristic (ROC) analyses and categorized according to the type of operation and stimulation. Results In spinal operations under transcranial stimulation, amplitude reduction of 77.9% and 80.6% as cutoff points for motor palsy with and without CMAP normalization, respectively, provided a sensitivity of 100% and specificity of 96.8% and 96.5%. In aneurysmal operations under transcranial stimulation, cutoff points of 70.7% and 69.6% offered specificities of 95.2% and 95.7% with and without CMAP normalization, respectively. The sensitivities for both were 100%. In brain tumor operations under direct stimulation, cutoff points were 83.5% and 86.3% with or without CMAP normalization, respectively, and the sensitivity and specificity for both were 100%. Conclusion An amplitude decrease of 80% in brain tumor operations, 75% in spinal operations, and 70% in aneurysmal operations should be used as the cutoff points.

We clinically examined the efficacy of motor evoked potential (MEP) by transcranial highvoltage electrical stimulation for intraoperative monitoring in cerebro-vascular disease. In 49 neurosurgical operations for cerebro-vascular disease, transcranial MEP (TCMEP) was recorded by 300-1000 V bipolar stimulation using the screw electrodes with the anode on the affected side. Surface electrodes for electromyographic responses were placed on the bilateral abductor pollicis brevis (APB) and bilateral abductor hallucis (AH) muscles. To remove effects of muscle relaxants on

Purpose: Anesthetic fade refers to the time-dependent decrease in the amplitude of the intraoperative motor-evoked potential. It is thought to be caused by the accumulation of propofol. The authors examined whether normalization by the compound muscle action potential (CMAP) after peripheral nerve stimulation could compensate for anesthetic fade.Methods: In 1,842 muscles in 578 surgeries, which did not exhibit a motor-neurologic change after the operation, the motor-evoked potential amplitude was normalized by the CMAP amplitude after peripheral nerve stimulation, and the CMAP amplitude and operation times were analyzed.